A citation-based method for searching scientific literature

Martina Amanzio, Dimos D Mitsikostas, Fabio Giovannelli, Massimo Bartoli, Giuseppina Elena Cipriani, Walter A Brown. Lancet Reg Health Eur 2022
Times Cited: 9







List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
Kate R Woodworth, Danielle Moulia, Jennifer P Collins, Stephen C Hadler, Jefferson M Jones, Sujan C Reddy, Mary Chamberland, Doug Campos-Outcalt, Rebecca L Morgan, Oliver Brooks,[...]. MMWR Morb Mortal Wkly Rep 2021
33
11


Prospects for a MERS-CoV spike vaccine.
Yusen Zhou, Shibo Jiang, Lanying Du. Expert Rev Vaccines 2018
76
11

Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine.
Yaki Saciuk, Jennifer Kertes, Naama Shamir Stein, Anat Ekka Zohar. J Infect Dis 2022
17
11

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
Kathleen Dooling, Julia W Gargano, Danielle Moulia, Megan Wallace, Hannah G Rosenblum, Amy E Blain, Stephen C Hadler, Ian D Plumb, Heidi Moline, Jack Gerstein,[...]. MMWR Morb Mortal Wkly Rep 2021
10
11

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Mark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Vanessa Raabe, Ruth Bailey, Kena A Swanson,[...]. Nature 2020
691
11

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
Lisa A Jackson, Evan J Anderson, Nadine G Rouphael, Paul C Roberts, Mamodikoe Makhene, Rhea N Coler, Michele P McCullough, James D Chappell, Mark R Denison, Laura J Stevens,[...]. N Engl J Med 2020
11

COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
Farren Basil Shaw Briggs, Farrah J Mateen, Hollie Schmidt, Keisha M Currie, Heather M Siefers, Slavka Crouthamel, Bruce F Bebo, Julie Fiol, Michael K Racke, Kevin C O'Connor,[...]. Neurol Neuroimmunol Neuroinflamm 2021
4
25

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, Ben Y Reis, Ran D Balicer. Lancet 2021
192
11

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Yushun Wan, Jian Shang, Shihui Sun, Wanbo Tai, Jing Chen, Qibin Geng, Lei He, Yuehong Chen, Jianming Wu, Zhengli Shi,[...]. J Virol 2020
368
11

A new generation of vaccines based on alphavirus self-amplifying RNA.
María Cristina Ballesteros-Briones, Noelia Silva-Pilipich, Guillermo Herrador-Cañete, Lucia Vanrell, Cristian Smerdou. Curr Opin Virol 2020
11
11

Origin and evolution of pathogenic coronaviruses.
Jie Cui, Fang Li, Zheng-Li Shi. Nat Rev Microbiol 2019
11

DNA Mediated Vaccines Delivery Through Nanoparticles.
Muhammad Ali A Shah, Zeeshan Ali, Rasheed Ahmad, Ishtiaq Qadri, Kaneez Fatima, Nongyue He. J Nanosci Nanotechnol 2015
28
11

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
Vivek Shinde, Sutika Bhikha, Zaheer Hoosain, Moherndran Archary, Qasim Bhorat, Lee Fairlie, Umesh Lalloo, Mduduzi S L Masilela, Dhayendre Moodley, Sherika Hanley,[...]. N Engl J Med 2021
256
11


Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
Cheryl Keech, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou,[...]. N Engl J Med 2020
560
11

An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies.
Naru Zhang, Jian Shang, Chaoqun Li, Kehui Zhou, Lanying Du. Expert Rev Vaccines 2020
3
33

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.
Sham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, Linda J Rennick, Zhe Sang, William B Klimstra, Douglas S Reed, Nicholas A Crossland, Yi Shi, W Paul Duprex. Sci Adv 2021
46
11

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
Fang Li, Wenhui Li, Michael Farzan, Stephen C Harrison. Science 2005
11

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain.
Xiaojing Chi, Xiuying Liu, Conghui Wang, Xinhui Zhang, Xiang Li, Jianhua Hou, Lili Ren, Qi Jin, Jianwei Wang, Wei Yang. Nat Commun 2020
74
11

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C Walls, Young-Jun Park, M Alejandra Tortorici, Abigail Wall, Andrew T McGuire, David Veesler. Cell 2020
11

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
Liane Rabinowich, Ayelet Grupper, Roni Baruch, Merav Ben-Yehoyada, Tami Halperin, Dan Turner, Eugene Katchman, Sharon Levi, Inbal Houri, Nir Lubezky,[...]. J Hepatol 2021
131
11

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, Samuel Wrenn, Minh N Pham, Michael Murphy, Longping V Tse, Laila Shehata, Megan A O'Connor, Chengbo Chen,[...]. Cell 2020
196
11

Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Christian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen, Signe Risbøl Vils, Clara Elbaek Mistegård, Anders Dahl Johannsen, Marie-Louise From Hermansen, Marianne Kragh Thomsen, Christian Erikstrup, Ellen-Margrethe Hauge,[...]. ACR Open Rheumatol 2021
32
11

Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou,[...]. Blood Adv 2021
11
11

A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe psoriasis.
Danka Svecova, Martin W Lubell, Florence Casset-Semanaz, Harald Mackenzie, Roland Grenningloh, James G Krueger. J Am Acad Dermatol 2019
26
11

Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.
Sergio Linares-Fernández, Céline Lacroix, Jean-Yves Exposito, Bernard Verrier. Trends Mol Med 2020
75
11


An Update on Self-Amplifying mRNA Vaccine Development.
Anna K Blakney, Shell Ip, Andrew J Geall. Vaccines (Basel) 2021
36
11


A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
Kathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, Elizabeth J Martinez, Ines Lakhal-Naouar, Linda L Jagodzinski, Dominic Paquin-Proulx, Gregory D Gromowski, Isabella Swafford, Akshaya Ganesh,[...]. NPJ Vaccines 2021
12
11

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
Sara E Oliver, Julia W Gargano, Mona Marin, Megan Wallace, Kathryn G Curran, Mary Chamberland, Nancy McClung, Doug Campos-Outcalt, Rebecca L Morgan, Sarah Mbaeyi,[...]. MMWR Morb Mortal Wkly Rep 2020
245
11

Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model.
Kei Haga, Reiko Takai-Todaka, Yuta Matsumura, Chihong Song, Tomomi Takano, Takuto Tojo, Atsushi Nagami, Yuki Ishida, Hidekazu Masaki, Masayuki Tsuchiya,[...]. PLoS Pathog 2021
9
11

Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.
Uri Elia, Shahar Rotem, Erez Bar-Haim, Srinivas Ramishetti, Gonna Somu Naidu, David Gur, Moshe Aftalion, Ma'ayan Israeli, Adi Bercovich-Kinori, Ron Alcalay,[...]. Nano Lett 2021
7
14

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini,[...]. N Engl J Med 2021
313
11

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
Vivek Naranbhai, Claire A Pernat, Alexander Gavralidis, Kerri J St Denis, Evan C Lam, Laura M Spring, Steven J Isakoff, Jocelyn R Farmer, Leyre Zubiri, Gabriela S Hobbs,[...]. J Clin Oncol 2022
15
11

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
Audrey Dionne, Francesca Sperotto, Stephanie Chamberlain, Annette L Baker, Andrew J Powell, Ashwin Prakash, Daniel A Castellanos, Susan F Saleeb, Sarah D de Ferranti, Jane W Newburger,[...]. JAMA Cardiol 2021
44
11

Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery.
Jasmine E Francis, Ivana Skakic, Chaitali Dekiwadia, Ravi Shukla, Aya C Taki, Anna Walduck, Peter M Smooker. Vaccines (Basel) 2020
5
20

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients.
Andrew H Karaba, Xianming Zhu, Tao Liang, Kristy H Wang, Alex G Rittenhouse, Olivia Akinde, Yolanda Eby, Jessica E Ruff, Joel N Blankson, Aura T Abedon,[...]. medRxiv 2021
4
25

The promise of mRNA vaccines: a biotech and industrial perspective.
Nicholas A C Jackson, Kent E Kester, Danilo Casimiro, Sanjay Gurunathan, Frank DeRosa. NPJ Vaccines 2020
128
11

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Guangyu Zhao, Lei He, Shihui Sun, Hongjie Qiu, Wanbo Tai, Jiawei Chen, Jiangfan Li, Yuehong Chen, Yan Guo, Yufei Wang,[...]. J Virol 2018
58
11

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, Shazia Ali, Haitao Gao, Rafia Bhore, Bret J Musser, Yuhwen Soo, Diana Rofail, Joseph Im,[...]. N Engl J Med 2021
757
11

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database.
Rimple Jeet Kaur, Siddhartha Dutta, Jaykaran Charan, Pankaj Bhardwaj, Ankita Tandon, Dharamveer Yadav, Salequl Islam, Mainul Haque. Int J Gen Med 2021
13
11

The role of nanotechnology in the treatment of viral infections.
Lavanya Singh, Hendrik G Kruger, Glenn E M Maguire, Thavendran Govender, Raveen Parboosing. Ther Adv Infect Dis 2017
115
11

Cell entry mechanisms of SARS-CoV-2.
Jian Shang, Yushun Wan, Chuming Luo, Gang Ye, Qibin Geng, Ashley Auerbach, Fang Li. Proc Natl Acad Sci U S A 2020
11


Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.
Linda van Oosten, Jort J Altenburg, Cyrielle Fougeroux, Corinne Geertsema, Fred van den End, Wendy A C Evers, Adrie H Westphal, Simon Lindhoud, Willy van den Berg, Daan C Swarts,[...]. mBio 2021
7
14

Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
Rachna T Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V Schoenle, Kameron L Peyton, Jennifer L Uhrlaub, Tyler J Ripperger, Mladen Jergović,[...]. Nat Med 2021
56
11

Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination.
Benjamin Kahn, Sokratis A Apostolidis, Vatsal Bhatt, Allison R Greenplate, Staci Kallish, Anthony LaCava, Alfredo Lucas, Nuala J Meyer, Dan Negoianu, Alexis R Ogdie,[...]. Crit Care Explor 2021
2
50

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.
Aharona Glatman-Freedman, Yael Hershkovitz, Zalman Kaufman, Rita Dichtiar, Lital Keinan-Boker, Michal Bromberg. Emerg Infect Dis 2021
18
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.